16.11
-0.10
(-0.62%)
As of 12:08:09 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -0.07 | -0.01 | -0.07 | 0.24 |
| Low Estimate | -0.15 | -0.06 | -0.34 | -0.35 |
| High Estimate | 0.02 | 0.03 | 0.05 | 0.58 |
| Year Ago EPS | -0.12 | 0 | -0.07 | -0.07 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 10 | 10 |
| Avg. Estimate | 38.74M | 44.15M | 178.82M | 219.37M |
| Low Estimate | 37.87M | 39.7M | 162.8M | 191.42M |
| High Estimate | 40.92M | 49.82M | 196.94M | 245.6M |
| Year Ago Sales | 29.51M | 34.89M | 139.93M | 178.82M |
| Sales Growth (year/est) | 31.26% | 26.54% | 27.79% | 22.68% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.19 | -0.11 | -0.07 | -0.01 |
| EPS Actual | -0.12 | 0 | 0 | 0.03 |
| Difference | 0.07 | 0.11 | 0.07 | 0.04 |
| Surprise % | 36.44% | 100.64% | 100.00% | 449.65% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.07 | -0.01 | -0.07 | 0.24 |
| 7 Days Ago | -0.06 | -0.01 | -0.06 | 0.3 |
| 30 Days Ago | -0.07 | -0.01 | -0.06 | 0.3 |
| 60 Days Ago | -0.03 | 0.02 | 0.14 | 0.55 |
| 90 Days Ago | -0.01 | 0.03 | 0.18 | 0.66 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RXST | 45.10% | -1,695.71% | -3.20% | 431.94% |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Downgrade | JP Morgan: Overweight to Underweight | 4/4/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 4/3/2025 |
| Reiterates | Needham: Buy to Buy | 4/3/2025 |
| Maintains | B of A Securities: Buy to Buy | 3/21/2025 |
| Maintains | Stifel: Hold to Hold | 3/19/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 2/26/2025 |
Related Tickers
TMDX TransMedics Group, Inc.
66.98
-5.61%
SGHT Sight Sciences, Inc.
2.2600
+1.35%
GKOS Glaukos Corporation
83.65
-3.85%
PRCT PROCEPT BioRobotics Corporation
52.89
-3.45%
NPCE NeuroPace, Inc.
12.25
-5.84%
DCTH Delcath Systems, Inc.
10.86
-9.54%
LNSR LENSAR, Inc.
13.90
-1.14%
MASI Masimo Corporation
145.98
-4.19%
TELA TELA Bio, Inc.
1.0450
-10.64%
BBNX Beta Bionics, Inc.
9.71
-9.84%